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ORIGINAL PAPER
Inadequate Cancer Screening: Lack of 
Provider Continuity is a Greater Obstacle 
than Medical Mistrust
Lauren D. Arnold, PhD, MPH (co- First Author, fi rst listed)
Martha M. O. McGilvray, MSt, BA (co- First Author, second listed)
J. Kyle Cooper, BA
Aimee S. James, PhD, MPH
Abstract: Background. Racial minorities and low- income individuals are generally less likely 
to have adequate cancer screening than Whites or  higher- income individuals. Purpose. To 
examine the roles of medical mistrust and lack of provider continuity in cancer screening 
in a low- income minority population. Methods. A total of 144 urban federally qualifi ed 
health center patients completed a  cross- sectional survey that included the Group Based 
Medical Mistrust Scale and questions on provider continuity and  cancer- screening- history. 
Results. Breast cancer screening was associated with continuity of care but not mistrust 
(respectively p = .002, p > .05); colon cancer screening was not signifi cantly associated with 
either factor (p > .05). Conclusions. Findings suggest that among low- income minority 
adults continuity of care is more strongly associated with screening than medical mistrust. 
Shift ing focus from medical mistrust—a  patient- level issue—to establishing health care 
homes—a  system- level issue—may be a more eff ective strategy for reducing racial and 
socioeconomic disparities in cancer screening. 
Key words: Mistrust, continuity of care, cancer screening, racial minorities, low income, 
breast cancer, colon cancer
Cancer mortality is disproportionately prevalent among racial minorities and low- income individuals.1,2 Compared with their White counterparts, Blacks experience 
higher mortality for all cancers combined, and for breast and colon cancer individually.3 
Low- income individuals also experience higher mortality for breast cancer and colorec-
tal cancer (CRC).4,5 One major factor fueling these disparities is late- stage diagnosis, 
which leads to worse initial prognosis.1
Cancer screening reduces CRC and breast cancer mortality.6–11 Despite this, many 
individuals in the U.S. do not receive screening at recommended intervals, especially 
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racial minorities and low- income individuals.2,12–14 For example, national survey data 
found that only 44.2% and 56.3% of individuals with an income less than 139% of 
the federal poverty threshold had recent CRC screening and recent mammography, 
respectively, compared with 65.5% and 81.8% of individuals with an income greater 
than 400% of the poverty threshold.12 
There are a plethora of commonly cited potential factors associated with suboptimal 
cancer screening.12,13,15–20 Two important but less well characterized proposed factors 
are medical mistrust (i.e., mistrust of the health care system or providers) and lack of 
provider continuity (i.e., having a consistent provider or health care home).21–26 La Veist 
et  al. showed that mistrust toward health care organizations leads to failure to take 
medical advice and to keep  follow- up appointments,27 while Brookhart et al. showed 
that provider continuity is positively associated with medical adherence.28 Given that 
medical mistrust and lack of provider continuity are thought to be more common 
among racial minorities and low- income populations,25,29–32 their potential role in the 
observed cancer mortality disparities among these groups should be explored. 
Both medical mistrust and lack of provider continuity are linked to complicated 
structures of racial and socioeconomic discrimination, and the resulting lack of social 
resources and support. Thus, neither is easily ameliorated. When prioritizing one fac-
tor as a fi rst target for intervention, an important preliminary question is: is one of 
these two factors more signifi cantly linked to adequacy of cancer screening, and thus 
disparities in mortality? Survey data from a  cross- sectional study in a low- income 
minority population were used to explore this question.
Methods
Overview and study design. Survey data were collected from patients at a network 
of urban federally qualifi ed health centers (FQHCs) as part of a longitudinal, obser-
vational study on CRC screening behaviors. This  cross- sectional analysis of baseline 
data was performed to investigate potential associations between cancer screening and 
both medical mistrust (a scale variable) and provider continuity (a binary categorical 
variable). Study procedures were approved by the Washington University in Saint Louis 
School of Medicine (Saint Louis, MO) Institutional Review Board.
Participants. Participants were recruited from the patient populations of three 
FQHCs in St. Louis, Missouri. Patients were eligible to participate if they spoke English 
and were 40 years of age or older. Participants received a $15 gift  card upon survey 
completion.
Measures. Participants completed a baseline survey, either by  interviewer- administration 
(69%) or on their own (31%). Outcomes of interest were ever having been screened 
for CRC or breast cancer as assessed by self- report. Screening measures queried were 
fecal occult blood testing (FOBT), fl exible sigmoidoscopy, and colonoscopy for CRC 
and mammography for breast cancer. National Cancer Institute (NCI) CRC screening 
measures33 were used in their original form to measure CRC screening and in modifi ed 
form to measure breast cancer screening. The two primary independent variables were 
medical mistrust and provider continuity. Mistrust was evaluated using the Group- 
Based Medical Mistrust Scale (α = 0.877). This scale was designed to assess mistrust 
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within the context of health care and racial discrimination and has been validated in 
Black men and women.34,35 Individuals were categorized as having provider continu-
ity if they answered “yes” to the question “Is there a particular doctor’s offi  ce, clinic, 
or health center that you regularly go to when you are sick?” Additional variables 
of interest included age, gender, race, education level, income level, and insurance 
status. 
Analysis. Total medical mistrust scores were calculated by summing scores for the 
12 individual items generating a scale from 0 to 60, with a higher score indicating a 
greater level of mistrust. Medical mistrust scale scores were then assessed across groups 
categorized by age, race, gender, income, and insurance status using t- tests, and groups 
categorized by education level using ANOVA. Continuity of care was assessed across 
those same groups using chi- square tests. The association between medical mistrust 
and continuity of care was evaluated using a t- test. 
American Cancer Society screening guidelines were used to identify the appropri-
ate subpopulations for analysis of specifi c cancer screening modalities: mammogra-
phy analysis was restricted to women ≥40 years and CRC screening analysis to men 
and women ≥50 years. Based on their yes/no answers to screening history questions, 
participants were scored as either had ever been screened or had never been screened 
for mammography and for any CRC screening (FOBT, sigmoidoscopy, colonoscopy). 
Mistrust and provider continuity were assessed across ever/never screened groups by 
t- tests and chi- square tests, respectively. All analyses were conducted using IBM SPSS 
Statistics v.22.36 
Results
Demographic characteristics. The sample population consisted of 144 individuals 
(Table 1) with a mean age of 51 years (SD = 7) who were predominately Black and 
male (87.5% and 61.8%, respectively). Over one third (36.1%) of participants had not 
completed high school or attained a GED , and about one quarter (24.3%) reported 
education beyond high school. Participants faced considerable socioeconomic challenges. 
The majority (70.8%) reported a monthly income below $800 (less than $9,600 annu-
ally). A similarly large proportion (75.0%) reported having ever been homeless (i.e., 
ever spent longer than 24 hours on the streets or in a shelter). Uninsured participants 
comprised 52.1% of the sample population, with an additional 10.4% reporting that 
despite having insurance at the time of the survey, they had experienced a coverage 
gap in the previous 12- month period. Despite the high percentage of uninsured par-
ticipants, 84.7% reported they had a regular health care source. This likely refl ects the 
health center based recruitment strategy and the eligibility requirement for participants 
to be a patient at these centers. 
 Medical mistrust demographic characteristics. A total of 123 individuals had 
complete responses to the 12- item Group- Based Medical Mistrust Scale. Signifi cant 
diff erences in mistrust were seen across groups by race and insurance status (Table 2). 
Blacks had higher mistrust scores than individuals of other races (mean(SD): 31.0(9.1) 
vs. 26.2(8.4); p = .04). Individuals with health insurance had higher levels of mistrust 
than uninsured individuals (mean(SD): 32.0(9.8) vs. 28.6(8.2); p  = .04). There were 
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no signifi cant diff erences in mistrust by gender, highest level of education, or monthly 
income. A selection of the most commonly endorsed mistrust statements are shown 
in Table 3.
 Provider- continuity demographic characteristics. A total of 143 individuals 
responded to the  provider- continuity question (Table 4). A signifi cant diff erence in pro-
vider continuity was only seen across groups by insurance status. A greater percentage 
of individuals with health insurance had a regular provider than uninsured individuals 
(93.8% vs. 79.7%; χ2 = 5.68 [df = 1], p = .02). There were no signifi cant diff erences in 
provider continuity by race, gender, highest level of education, or monthly income.
 Medical mistrust vs. provider continuity. Medical mistrust and provider continuity 
were not signifi cantly associated (n = 122; p = .85).
Cancer screening by medical mistrust vs. provider continuity. Among women 
40 years or older who responded to the relevant survey questions, there was a sig-
nifi cant diff erence in history of mammography across groups by provider continuity 
(n = 55, χ2 = 9.75 [df = 1], p = .002; Table 5) but not by medical mistrust (n = 45, p = 




Mean (±SD) or 
frequency (proportion)  
Age (years) 51 (±7)
Race
 Black 126 (87.5%)
 Other 18 (12.5%)
Gender
 Male 89 (61.8%)
 Female 55 (38.2%)
Highest Level of Education
 < high school (HS) graduation or GED 52 (36.1%)
 HS graduation or GED 55 (38.2%)
 > HS graduation or GED 35 (24.3%)
Employment Status
 Unemployed (non-disabled) 71 (49.3%)
Monthly Income
 < $800 102 (70.8%)
 ≥ $800 33 (22.9%)
Insurance Status
 Uninsured 75 (52.1%)
 Insured 64 (44.4%)
aN = 144. Percentages within individual demographic factors may not sum to 100% due to  participant- 
omitted answers.
Table 2. 
MEDICAL MISTRUST BY DEMOGRAPHIC CHARACTERISTICSa
Demographic characteristic Sample Size  
Medical Mistrust 
Score (mean ± SD)  p- value
Race
 Black 105 31.0 ± 9.1 .04
 Other 18 26.2 ± 8.4
Gender
 Male 78 30.1 ± 9.3 .73
 Female 45 30.7 ± 8.9
Highest Level of Education
 < HS grad or GED 44 31.8 ± 8.0 .19
 HS grad or GED 47 30.2 ± 9.5
 > HS grad or GED 30 27.9 ± 9.4
Monthly Income
 < $800 89 30.0 ± 9.1 .79
 ≥ $800 27 30.5 ± 9.5
Insurance Status
 Uninsured 69 28.6 ± 8.2 .04
 Insured 50 32.0 ± 9.8
aMistrust measured by the Group Based Medical Mistrust Scale with scores ranging from 0 to 60; a 
higher score indicates a greater level of mistrust. 
Table 3. 
REPONSES TO SELECTED ITEMS FROM THE GROUP BASED 
MEDICAL MISTRUST SCALE
Mistrust Item  Population % (n)a
Doctors and health care workers sometimes hide information 
from patients who belong to my ethnic group.
36% (49)
Doctors and health care workers treat people of my ethnic 
group as “guinea pigs”.
25% (33)
I have personally been treated poorly or unfairly by doctors or 
health care workers because of my ethnicity. 
22% (30)
People of my ethnic group cannot trust doctors and health care 
workers.
17% (23)
aSample sizes for each question refl ect the total number of participants who answered that question 
(in descending order: n = 135, 134, 136, 136). Participants who answered either “Strongly Agree” or 
“Agree” were included in the percentages reported above.
Table 4. 
CONTINUITY OF MEDICAL CARE BY DEMOGRAPHIC 
CHARACTERISTICS
Demographic characteristic Sample Size  
Has a Regular 
Provider 
(proportion)  p- value
Race
 Black 125 84.0% .24
 Other 18 94.4%
Gender
 Male 88 84.1% .60
 Female 55 87.3%
Highest Level of Education
 < HS grad or GED 51 80.4% .07
 HS grad or GED 55 81.8%
 > HS grad or GED 35 97.1%
Monthly Income
 < $800 102 83.3% .13
 ≥ $800 33 93.9%
Insurance Status
 Uninsured 74 79.7% .02
 Insured  64  93.8%   
Table 5. 
RATES OF CANCER SCREENING BY LEVEL OF MEDICAL 
MISTRUST AND CONTINUITY OF CARE
Screening 
modality  




(mean ± SD)  p- value  
Sample 
size  
Has a Regular 
Provider 
(proportion)  p- value
Mammogram
 Ever 37 30.9 ± 9.5 .81 46 93.5% .002
 Never 8 30.0 ± 6.0 9 55.6%
CRC Screening
 Ever 37 31.9 ± 10.1 .68 42 92.9% .06
 Never 30 30.9 ± 8.3 37 78.4%
CRC =  Colorectal Cancer
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have ever received breast cancer screening than individuals without continuity of care 
(93.5% vs. 55.6%).
 Among individuals aged 50 or older, those who had provider continuity had higher 
rates of CRC screening than those without continuity —92.9% of individuals with con-
tinuity had ever received CRC screening vs. 78.4% without—but the diff erence was 
not statistically signifi cant (n = 79, p = .06). In contrast, individuals who had received 
CRC screening had a higher mean mistrust score than those who had not received 
screening (mean ± SD: ever CRC screening 31.9 ± 10.1 vs. never CRC screening 30.9 
± 8.3), but again this result was not signifi cant (n = 67, p = .68). 
Additional analyses. Race, education and income levels, and insurance status were 
not signifi cantly associated with either mammography or CRC screening, and gender 
was also not signifi cantly associated with CRC screening (all p values > .05). 
Discussion
Key fi ndings. The study population faced pronounced disparities—most participants 
were below the national poverty line, had at some point been homeless, and lacked post- 
secondary education. Within this population, we examined the associations of medical 
mistrust and provider continuity with cancer screening, and found that continuity 
was more strongly associated with having ever had mammography than was mistrust. 
This  cross- sectional survey study found that continuity of medical care, but not 
medical mistrust, was signifi cantly associated with adequate breast cancer screening. 
That having a regular provider is important for maintaining a good standard of care is 
consistent with previous studies37–39 and is conceptually logical. Patients and physicians 
can only develop a therapeutic relationship when they have repeated clinical encounters. 
Such a relationship enables the physician to gain a more complete picture of the patient’s 
medical history and screening/preventative needs. Regular use of the same clinical offi  ce 
or team also creates a secure and familiar space in which the patient and provider can 
discuss the patient’s health and health care plan in a non- emergent setting.37–39 
Given that other studies have linked medical mistrust with inadequate care,27,40–42 it 
may seem surprising that in this study population, high levels of medical mistrust were 
not associated with inadequate breast cancer screening. However, the interplay of mis-
trust, screening/preventive medicine, and patient outcomes is likely quite complicated 
and not easily captured using a 12- item tool. The Group Based Medical Mistrust Scale 
asks general questions about health care providers and the medical fi eld, with most 
questions oriented toward how a group of people are treated, rather than the individual 
answering the questions (e.g., “people of my ethnic group”). These questions do not 
assess an individual patient’s level of trust in a specifi c provider or institution, which 
may 1) vary signifi cantly from their level of trust in the medical fi eld as a whole, and 
2) be much more functionally relevant for adherence to prevention guidelines.
Indeed, it would be an oversimplifi cation to claim that provider continuity and 
mistrust—and their impact on quality/adequacy of care—are independent from each 
other. It is diffi  cult for a patient to build trust with a provider they meet only once or 
a clinic they use only once, and presumably more feasible to build trust with a familiar 
provider one expects to see again. This idea is supported by a number of studies that 
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have found continuity of care is positively correlated with medical trust across sample 
populations and more specifi cally within minority subgroups.37,43 Furthermore, in a 
sample of 1,031 men Carpenter et al. found that having a regular provider was associ-
ated both with greater trust and with screening for prostate cancer.25
Many studies have investigated the complex relationships between race, mistrust, 
provider continuity, and health care utilization,23,26,27,29,30,34,41,44–47 but as a fi eld, public 
health is still only beginning to understand these complex interconnections. There are 
a variety of mistrust measures that have been used to investigate these questions: the 
Medical Mistrust Index,29 the Primary Care Assessment Survey,48 the Stanford Trust 
in Physician Scale,49 and the Group- Based Medical Mistrust Scale (used in the current 
study). Many of these measures ask about patients as a group or as members of specifi c 
racial or ethnic groups, providers as a whole, or the health care system as a singular 
entity. Some ask about a patient’s experience with the health care system as a whole, or 
even a specifi c relationship between one patient and one doctor, but leave out queries 
concerning race and racial discrimination. To our knowledge, no studies have simul-
taneously asked about an individual patient’s experience with an individual provider 
with specifi c reference to the role the patient’s race plays in that interaction. Perhaps 
this is a gap in our literature that it would be important and enlightening to fi ll in.
However, investigating this gap could be analytically quite complex. Should the 
specifi c provider be designated as the provider/practice the individual visits most oft en, 
or whatever practice is chosen as the point of study recruitment/participation? How 
can individuals whose regular provider is a physician be compared with those whose 
regular provider is a nurse practitioner or physician’s assistant, or some combination 
thereof? How can such a measure be standardized across both populations with and 
without a regular provider? Regarding the latter question, some studies have opted to 
only include those potential participants who do have a regular care home,48,49 but in 
doing so have resigned themselves to not addressing an important side of the mistrust 
issue. Measuring medical mistrust by treating the entire medical fi eld as a single entity 
has practical benefi ts in that it allows for comparison across individuals with disparate 
access to and interaction with medical providers. Unfortunately, the same simplicity 
that makes such a measure methodologically attractive may miss an important element 
of mistrust. 
Advantages and limitations. While this study comes to a potentially important 
conclusion that continuity of care may be a larger driver of screening behavior than 
medical mistrust among low- income primary care patients, it is important to keep in 
mind its limitations. First, because this is a  cross- sectional study, it is not possible to 
assess causal relationships between cancer screening behaviors and both mistrust and 
provider continuity. Secondly, this study relied on participant self- report for screening 
history and provider continuity. Although this may not always be accurate, several stud-
ies have supported the use and validity of self- report for assessing cancer screening.33,50 
Third, knowing that participants usually see the same provider at the FQHCs in this 
study, continuity of care was operationalized as having a usual clinic or offi  ce where 
care is obtained. While it can be argued that continuity and usual source of care are 
diff erent concepts, there is evidence that having a regular provider at a usual source 
is more eff ective than having a usual source of care alone.51,52 Thus, due to the way 
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continuity was defi ned in this study, the magnitude of association between continuity 
and cancer screening may be underestimated. 
As previously noted, a more comprehensive medical mistrust measure that asks 
participants to evaluate their own interactions with a specifi c provider/practice and 
with the more general health care system as a whole, while also assessing the role 
race plays in those interactions might better characterize this complex matter. The 
Group Based Medical Mistrust Scale was developed and tested in African American 
and Latina women for the purpose of assessing medical mistrust as it relates to racial/
ethnic health disparities.34 While race and ethnicity are diff erent concepts, the Scale 
uses “ethnicity” as an encompassing term for both race and ethnicity, and it has been 
validated among Blacks, demonstrating applicability to race. Because a predominantly 
African American sample, such as that in this study, is likely to over- represent those 
who have high mistrust, future studies might utilize quota sampling to recruit other 
racial/ethnic groups and thereby minimize homogeneity of the sample. 
Additionally, the small sample size (n = 144) limited the study’s ability to detect sig-
nifi cant diff erences, draw more defi nitive conclusions, and adjust analyses by multiple 
demographic variables. This limitation was more pronounced when isolating subgroups 
that were eligible for mammography or CRC screening and had also completed the 
mistrust or  provider- continuity measures. For example, almost two thirds of the sample 
population was male and thus not eligible for standard breast cancer screening. Despite 
the small sample size, this study was able to gain insight into a unique population 
underrepresented in published research. The demographic make- up, in particular the 
relatively homogeneous nature of the sample population (i.e., mostly Black, low- income) 
may have also contributed to the lack of expected correlation observed between demo-
graphic characteristics and cancer screening. This homogeneity also limited the study’s 
ability to make intergroup comparisons and to expand the study’s conclusions more 
generally outside of this specifi c population. In future studies, quota sampling could be 
used to ensure adequate representation of diff erent subpopulations (e.g. gender, race) 
to allow for  inter- group comparisons.
However, the demographic characteristics of the study population also add richness 
to our fi ndings. While it is oft en the case in survey studies that the majority of par-
ticipants are female,53–55 in this study the majority were male. This allows for insights 
to be drawn for a population oft en under represented both in research and in health 
care utilization more generally.56,57 The same can be said of the nearly homogeneous 
racial makeup, lack of higher education, and pronounced poverty of the sample popu-
lation—more than 70% of participants had an annual income of less than $10,000, 
placing them well below the national poverty threshold. While many studies have 
characterized populations at high risk for inadequate medical/preventative care, this 
study characterized a population at the very limit of high risk and low resources. Sam-
pling such an exceptionally high- risk and low- resource population allows this study to 
draw conclusions and propose future interventions targeted at those patients who are 
most in need. Such specifi c prioritization is especially important within the context of 
limited health care resources and health care disparities.
As the target population in this study was underserved individuals, a convenience 
sampling strategy was used with the sampling frame of FQHC patients. This popula-
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tion may include individuals who use a specifi c center for routine care as well as those 
who are transient and do not routinely visit a specifi c center. It is likely that due to 
this sampling strategy, individuals with a usual source of care are over- represented in 
the sample. To address this limitation, future studies may include a  community- based 
sampling component. 
Implications for future interventions. Medical mistrust and continuity of care are 
both complicated  systems- level issues. Medical mistrust is staggeringly complex and 
is inseparable from a long- standing history of institutionalized discrimination that 
reaches far beyond the borders of the health care fi eld. As such, it has no clear or simple 
solution. While continuity of care and the dearth of health care homes is a similarly 
complex issue, because it is directly within the purview of the health care system, it 
seems more feasibly solvable by those within that system. 
For some providers, it may be all too easy to dismiss individual patients’ non- 
adherence to medical guidelines out of hand, or indeed patients themselves as mis-
trusting, uninformed, or non- compliant. Prioritizing providing consistent longitudinal 
care can re- direct this  counter- productive focus on the perceived limitations of an 
individual patient instead into a productive improvement of the shortcomings of the 
health care system.39
This study in no way aims to minimize the importance of medical mistrust, and 
interventions to address this remain important. Indeed, this study’s fi ndings on mistrust 
are sobering (Table 3). Over a third of participants considered health care providers to 
be (intentionally or unintentionally)  racially- biased. A quarter of patients agreed that 
“doctors and health care workers treat people of my ethnic group as ‘guinea pigs’.” These 
simple statistics indicate potential challenges for members of racial/ethnic minority 
groups and low- income individuals interacting with the health care system and should 
inform future eff ort to ameliorate mistrust and its eff ects.
Medical mistrust is likely a mechanism of negative patient outcomes, but it could 
also be considered an outcome in and of itself. It would not be unreasonable to con-
clude that patients who at the completion of treatment or medical encounter do not 
trust their provider or feel that their care was negatively aff ected by their race have not 
received the standard of care. It may be more ethically cautious to conceptualize medi-
cal mistrust as an outcome rather than a patient attribute or mechanism as that will, 
at least to some extent, ensure that not all responsibility will be placed on the patient. 
As for functional application, interventions that build better continuity of care at the 
 systems- level, especially for high- risk populations, may improve both  cancer- screening 
rates and trust on the interpersonal level.
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